Nutra Pharma (OTCMKTS:NPHC) Stock Crosses Above 50 Day Moving Average – Should You Sell?

Nutra Pharma Corp. (OTCMKTS:NPHC)’s share price passed above its 50-day moving average during trading on Monday . The stock has a 50-day moving average of $0.00 and traded as high as $0.0001. Nutra Pharma shares last traded at $0.00, with a volume of 0 shares changing hands.

Nutra Pharma Stock Performance

About Nutra Pharma

Nutra Pharma Corporation is a development-stage medical technology company focusing on the research and development of therapeutic products for gastrointestinal disorders, notably those arising from opioid use. The company is advancing a portfolio of proprietary formulations designed to address opioid-induced constipation (OIC), a common side effect of pain management regimens.

Its lead candidate, RIMSO-50, is an oral solution being evaluated for its potential to alleviate OIC by promoting bowel movements without compromising the effectiveness of opioid analgesics.